MEI Pharma Allocates $100 Million to Litecoin Reserves, Appoints Creator Charlie Lee to Board
Biopharmaceutical firm MEI Pharma has executed a $100 million private placement to acquire Litecoin (LTC) as a reserve asset, issuing approximately 29.24 million shares at $3.42 each. This strategic allocation marks a significant corporate treasury shift toward blockchain-based assets. Concurrently,… Read More »MEI Pharma Allocates $100 Million to Litecoin Reserves, Appoints Creator Charlie Lee to Board